Today, Montse de Castellarnau, Scientific & Regulatory Affairs Officer at Asphalion, will be attending the “Workshop on support for orphan medicines development”. The workshop is organized by the EMA and it is aimed to facilitate the development of orphan medicines in neglected disease areas. The virtual event will highlight tools and incentives, such as Orphan designation, Protocol Assistance and the PRIME scheme.

Montse de Castellarnau is Medical writer at Asphalion and will participate in this workshop, where she will have the opportunity to interact with the EMA, as well as with stakeholders involved in orphan drugs development.

Asphalion has more than 20 years of experience on Regulatory procedures, and we can support Stakeholders throughout the drug development, including medicines for orphan diseases. If you would like to know more on how Asphalion can assist you, do not hesitate to contact us at info@asphalion.com.

Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Algoritmos para estudiar el lenguaje ayu...

by Agencia Sinc

La lucha constante entre los virus y nuestro sistema inmunitario guard...

Photos Stream